Digi.Bio Company
Digi.Bio is accelerating the development of life saving cell therapies with a lab-on-a-chip and computational platform that analyzes how cell therapies perform and evaluate their outcome down to the single cell level, delivering high content results in 24 hours and with minimal material waste.
Founded Date:
2017-01-01
Industry:
Cell & Gene Therapies
Funding Status:
private
Headquarters:
Amsterdam,Noord-Holland,The Netherlands,Europe